AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat
McCrimmon R.J., et al. AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat. Am. J. Physiol. Endocrinol. Metab. 2002, 283:E1076-E1083.
Correction of hyperglycemia with phloridzin restores the glucagon response to glucose in insulin-deficient dogs: implications for human diabetes
Starke A., et al. Correction of hyperglycemia with phloridzin restores the glucagon response to glucose in insulin-deficient dogs: implications for human diabetes. Proc. Natl. Acad. Sci. U.S.A. 1985, 82:1544-1546.
Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
Bonner C., et al. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nat. Med. 2015, 21:512-517.
Differences in glucose transporter gene expression between rat pancreatic alpha- and beta-cells are correlated to differences in glucose transport but not in glucose utilization
Heimberg H., et al. Differences in glucose transporter gene expression between rat pancreatic alpha- and beta-cells are correlated to differences in glucose transport but not in glucose utilization. J. Biol. Chem. 1995, 270:8971-8975.
Sugar binding to Na+/glucose cotransporters is determined by the carboxyl-terminal half of the protein
Panayotova-Heiermann M., et al. Sugar binding to Na+/glucose cotransporters is determined by the carboxyl-terminal half of the protein. J. Biol. Chem. 1996, 271:10029-10034.
In vitro reprogramming of pancreatic alpha cells towards a beta cell phenotype following ectopic HNF4alpha expression
Sangan C.B., et al. In vitro reprogramming of pancreatic alpha cells towards a beta cell phenotype following ectopic HNF4alpha expression. Mol. Cell. Endocrinol. 2015, 399:50-59.